Affiliation:
1. Headache Center of Rio
2. FIOCRUZ
Abstract
Several oral nonsteroidal anti-inflammatory drugs (NSAIDs) are effective to treat migraine attacks. Lysine clonixinate (LC) is a NSAID derived from nicotinic acid that has proven to be effective in various pain syndromes such as renal colic and muscular pain. The aim of this double-blind, placebo-controlled study was to evaluate the efficacy of oral LC compared to placebo in the acute treatment of migraine. Sixty four patients with the diagnosis of migraine, according to the IHS criteria, were studied prospectively. Patients received LC or placebo once the headache reached moderate or severe intensity for 6 consecutive attacks. With regard to the moderate attacks, LC was superior than placebo after 1, 2 and 4 hours. The consumption of other rescue medications after 4 hours was significantly higher in the placebo group. With regard to the severe attacks, there was no difference between the active drug group and the placebo group concerning headache intensity and consumption of other rescue medications. We conclude that the NSAID lysine clonixinate is effective in treating moderately severe migraine attacks. It is not superior than placebo in treating severe migraine attacks.
Subject
Neurology,Neurology (clinical)
Reference20 articles.
1. Migraine heterogeneity, disability, pain intensity, and attack frequency and duration;Stewart WF;Neurology,1994
2. Epidemiology of headache;Rasmussen BK;Cephalalgia,1995
3. The headaches;Tfelt-Hansen P,1993
4. Efficacy and safety of the nonprescription combination of acetaminophen, aspirin, and caffeine in alleviating headache pain of an acute migraine attack: three double-blind, randomized, placebo-controlled trials;Lipton RB;Arch Neurol,1998
5. Diclofenac-K (50 and 100mg) and placebo in the acute treatment of migraine;Dahlof C;Cephalalgia,1993
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献